Meeting Banner
Abstract #2976

Angiogenic Progression of the Human Breast Tumor in vivo: Is It Imaged?

Charles S. Springer1, 2, Ian J. Tagge1, Xin Li1, Luminita A. Tudorica1, 3, Sunitha B. Thakur4, 5, Karen Y. Oh3, Elizabeth A. Morris5, Nicole Roy<sup

1Advanced Imaging Research Center, Oregon Health & Science University, Portland, OR, United States; 2Knight Cancer Institute, Oregon Health & Science University, Portland, OR, United States; 3Diagnostic Radiology, Oregon Health & Science University, Portland, OR, United States; 4Medical Physics, Memorial Sloan Kettering Cancer Center, New York, United States; 5Radiology, Memorial Sloan Kettering Cancer Center, New York, United States; 6Biomedical Engineering, Oregon Health & Science University, Portland, OR, United States

A meta-population of 163 human breast tumors in vivo was studied by shutter-speed DCE-MRI. This spans three institutions, two magnetic field strengths, three instrument vendors, two initial screening modalities, three Gd contrast agents, and 21 lesion types. When the value of Ktrans is plotted vs. kep for all, a "threshold" behavior is manifest. The 120 benign lesion points are very tightly clustered near the origin, while the 43 malignant tumor values are strongly correlated, and some reach very large values. It is possible this is a manifestation of the metabolic "angiogenic switch" preceding breast tumor progression.

Keywords

acquisition advanced analyses analyzed approximation ascertained assessment assumes assumption behavior benign biomedical biopsies biopsy black blinded bolus breast cancer certain circles climb clustered colored combine concentration constant contrast control correlation detailed determined diagnostic diamonds dynamic efficacy enhanced equilibrium essentially fast features field findings furthermore health histograms human hypothesis important include independent independently indicates infinitely influential initial initiating input instrument invasive investigators kind knight latter least lesion lesions linear magnitudes malignant maps measures memorial metabolic might minimally model monitor morris near negative nonzero observing obvious occurs parametric pathology permeability pixel plot population populations positive potential preparing procedures progress progression quite radiology reagent recent remarkable represent respectively rise risk science screened screening secondly sector seem selected sense sensitive sequentially several shutter since software springer stage step strength strongly studied subjects subsequent sufficiently suggestive support systematic takes temporal though threshold tightly tumor tumors type types uncertainty underwent unidirectional usually variation view wall women years